An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials …
Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …
response in individuals and in clinical trials. Previously, asthma control, severity, and …
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - European Respiratory …, 2016 - Eur Respiratory Soc
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model
RJB Loymans, PJ Honkoop, EH Termeer… - Thorax, 2016 - thorax.bmj.com
Background Preventing exacerbations of asthma is a major goal in current guidelines. We
aimed to develop a prediction model enabling practitioners to identify patients at risk of …
aimed to develop a prediction model enabling practitioners to identify patients at risk of …
Impact of anxiety and depression on disease control and quality of life in asthma patients
I Urrutia, U Aguirre, S Pascual, C Esteban… - Journal of …, 2012 - Taylor & Francis
Introduction. Patients with asthma also tend to have anxiety and depression. These
comorbidities may affect asthma control and quality of life. The objective of this study was to …
comorbidities may affect asthma control and quality of life. The objective of this study was to …
Policy and system change and community coalitions: Outcomes from allies against asthma
NM Clark, L Lachance, LJ Doctor… - … Journal of Public …, 2010 - ajph.aphapublications.org
Objectives. We assessed policy and system changes and health outcomes produced by the
Allies Against Asthma program, a 5-year collaborative effort by 7 community coalitions to …
Allies Against Asthma program, a 5-year collaborative effort by 7 community coalitions to …
Implementing asthma guidelines using practice facilitation and local learning collaboratives: a randomized controlled trial
JW Mold, C Fox, A Wisniewski… - The Annals of Family …, 2014 - Annals Family Med
PURPOSE Guideline implementation in primary care has proven difficult. Although external
assistance through performance feedback, academic detailing, practice facilitation (PF), and …
assistance through performance feedback, academic detailing, practice facilitation (PF), and …
[HTML][HTML] Opportunities for cystic fibrosis care teams to support treatment adherence
Background The purpose of this study was to identify the extent to which pediatric and adult
cystic fibrosis (CF) care teams implement best practices in adherence assessment and …
cystic fibrosis (CF) care teams implement best practices in adherence assessment and …
The Pediatric Asthma Control and Communication Instrument asthma questionnaire: for use in diverse children of all ages
Background National Institutes of Health asthma guidelines recommend questionnaires to
assess asthma control, but these questionnaires are not useable across the entire pediatric …
assess asthma control, but these questionnaires are not useable across the entire pediatric …
Asthma: time to confront some inconvenient truths
Despite major advances in the understanding of the pathogenesis of asthma and
improvements in management, the accompanying benefits from public health initiatives and …
improvements in management, the accompanying benefits from public health initiatives and …
[HTML][HTML] Down-titration from high-dose combination therapy in asthma: removal of long-acting β2-agonist
BACKGROUND: Asthma guidelines recommend reducing inhaled corticosteroids (ICS) to
the minimum effective dose, but the timing of long-acting β2-agonist (LABA) withdrawal is …
the minimum effective dose, but the timing of long-acting β2-agonist (LABA) withdrawal is …